$SIGA
SIGA TECHNOLOGIES INC Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-Q Financial Statement

#000101008616000030 Filed on November 02, 2016

Income Statement

Concept	2016 Q4	2016 Q3	2015 Q3
Revenue	$7.200M	$4.700M	$1.300M
YoY Change	71.43%	261.54%	18.18%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.464M	$2.855M	$2.321M
YoY Change	73.83%	23.01%	-46.2%
% of Gross Profit
Research & Development	$8.158M	$6.069M	$2.427M
YoY Change	65.34%	150.06%	-11.49%
% of Gross Profit
Depreciation & Amortization	$40.00K	$42.66K	$52.29K
YoY Change	-20.0%	-18.42%	-40.06%
% of Gross Profit
Operating Expenses	$12.62M	$12.72M	$4.956M
YoY Change	68.25%	156.68%	-97.29%
Operating Profit	-$6.609M	-$8.062M	-$3.629M
YoY Change	-63.19%	122.15%	-98.0%
Interest Expense	-$3.100M	$94.78K	$0.00
YoY Change			-100.0%
% of Operating Profit
Other Income/Expense, Net	-$1.800M	$30.76K	$12.48K
YoY Change		146.38%	249560.0%
Pretax Income	-$10.40M	$9.200M	$5.600M
YoY Change	-47.74%	64.29%	-103.07%
Income Tax	$0.00	-$4.072K	$65.91K
% Of Pretax Income		-0.04%	1.18%
Net Earnings	-$10.44M	-$9.244M	-$5.631M
YoY Change	-48.05%	64.16%	-97.65%
Net Earnings / Revenue	-144.99%	-196.68%	-433.15%
Basic Earnings Per Share
Diluted Earnings Per Share	-$157.3K	-$169.4K	-$103.9K
COMMON SHARES
Basic Shares Outstanding	54.28M shares	53.87M shares	53.87M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q4	2016 Q3	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.70M	$20.50M	$129.3M
YoY Change	-74.53%	-84.15%	23.5%
Cash & Equivalents	$28.70M	$20.49M	$129.3M
Short-Term Investments
Other Short-Term Assets	$11.10M	$9.600M	$8.200M
YoY Change	1750.0%	17.07%	1071.43%
Inventory	$26.21M	$17.75M	$1.092M
Prepaid Expenses
Receivables	$3.154M	$38.75M	$979.2K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$69.16M	$86.58M	$139.5M
YoY Change	-46.58%	-37.94%	12.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$299.5K	$330.1K	$457.5K
YoY Change	-33.42%	-27.84%	-49.91%
Goodwill	$898.3K	$898.3K	$898.3K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$642.1K	$642.1K	$1.990M
YoY Change	-67.73%	-67.73%	-0.1%
Total Long-Term Assets	$91.82M	$76.26M	$57.65M
YoY Change	63.17%	32.27%	41.96%
TOTAL ASSETS
Total Short-Term Assets	$69.16M	$86.58M	$139.5M
Total Long-Term Assets	$91.82M	$76.26M	$57.65M
Total Assets	$161.0M	$162.8M	$197.2M
YoY Change	-13.33%	-17.41%	19.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.517M	$2.925M	$3.175M
YoY Change	-36.19%	-7.85%	366.25%
Accrued Expenses	$4.585M	$4.793M	$3.063M
YoY Change	35.3%	56.47%	59.08%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$7.102M	$108.3M	$6.238M
YoY Change	-3.15%	1636.51%	35.87%
LONG-TERM LIABILITIES
Long-Term Debt	$66.60M	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$374.5M	$367.4M	$448.1M
YoY Change	-19.04%	-18.01%	15.67%
Total Long-Term Liabilities	$441.1M	$367.4M	$448.1M
YoY Change	-4.65%	-18.01%	89603.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.102M	$108.3M	$6.238M
Total Long-Term Liabilities	$441.1M	$367.4M	$448.1M
Total Liabilities	$448.4M	$476.0M	$461.8M
YoY Change	-4.63%	3.07%	17.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$501.1M	-$490.7M	-$441.3M
YoY Change	8.6%	11.18%	9.53%
Common Stock	$213.7M	$177.5M	$176.7M
YoY Change	20.74%	0.48%	0.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$287.4M	-$313.2M	-$264.7M
YoY Change
Total Liabilities & Shareholders Equity	$161.0M	$162.8M	$197.2M
YoY Change	-13.33%	-17.41%	19.7%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2015 Q3
OPERATING ACTIVITIES
Net Income	-$10.44M	-$9.244M	-$5.631M
YoY Change	-48.05%	64.16%	-97.65%
Depreciation, Depletion And Amortization	$40.00K	$42.66K	$52.29K
YoY Change	-20.0%	-18.42%	-40.06%
Cash From Operating Activities	-$25.90M	-$56.23M	$13.70M
YoY Change	56.78%	-510.44%	35.38%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	$0.00	-$60.00K
YoY Change	-80.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$1.210M	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	$1.200M	$0.00	-$60.00K
YoY Change	-2500.0%	-100.0%	-98.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	60.38M	-1.290M	0.000
YoY Change	-603900.0%		-100.0%
NET CHANGE
Cash From Operating Activities	-25.90M	-56.23M	13.70M
Cash From Investing Activities	1.200M	0.000	-60.00K
Cash From Financing Activities	60.38M	-1.290M	0.000
Net Change In Cash	35.68M	-57.52M	13.64M
YoY Change	-315.2%	-521.7%	141.42%
FREE CASH FLOW
Cash From Operating Activities	-$25.90M	-$56.23M	$13.70M
Capital Expenditures	-$10.00K	$0.00	-$60.00K
Free Cash Flow	-$25.89M	-$56.23M	$13.76M
YoY Change	57.19%	-508.65%	35.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001010086
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	54284296	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SIGA TECHNOLOGIES INC
	dei	Trading Symbol TradingSymbol	SIGAQ
CY2016Q2	siga	Amount To Be Paid On Effective Dateof Plan Of Reorganization AmountToBePaidOnEffectiveDateofPlanOfReorganization	5000000	USD
CY2016Q3	siga	Classof Warrantor Right Periodfromwhich Warrantsor Rightsare Exercisable ClassofWarrantorRightPeriodfromwhichWarrantsorRightsareExercisable	P10Y
CY2012Q2	siga	Collateral Collateral	0.50
CY2015Q4	siga	Computer Equipment ComputerEquipment	754502	USD
CY2016Q3	siga	Computer Equipment ComputerEquipment	762977	USD
	siga	Expenseof Warrants Heldas Assets ExpenseofWarrantsHeldasAssets	45456	USD
	siga	Expenseof Warrants Heldas Assets ExpenseofWarrantsHeldasAssets	0	USD
CY2015Q1	siga	Finalorderandjudgmentplusinterest Finalorderandjudgmentplusinterest	195000000	USD
CY2015Q3	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	0	USD
	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	0	USD
CY2016Q3	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	1121530	USD
	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	1121530	USD
CY2016Q3	siga	Interest Accrual Rate InterestAccrualRate	0.0875
CY2015Q4	siga	Liabilitiessubjecttocompromiseaccountspayable Liabilitiessubjecttocompromiseaccountspayable	834219	USD
CY2015Q4	siga	Liabilitiessubjecttocompromiselosscontingencylegalfees Liabilitiessubjecttocompromiselosscontingencylegalfees	3200000	USD
CY2015Q4	siga	Liabilitiessubjecttocompromiseotheraccruedexpense Liabilitiessubjecttocompromiseotheraccruedexpense	737883	USD
CY2016Q3	siga	Net Capital Deficiency NetCapitalDeficiency	313000000	USD
	siga	Numberofcoursesdeliveredtothegovernment Numberofcoursesdeliveredtothegovernment	218000	USD
CY2016Q3	siga	Numberofcoursesof Tpox Xtobedeliveredtothegovernment NumberofcoursesofTPOXXtobedeliveredtothegovernment	51000	USD
CY2016Q3	siga	Numberofcoursestobedeliveredtothegovernmentincludingfreecourses Numberofcoursestobedeliveredtothegovernmentincludingfreecourses	627000	USD
CY2016Q3	siga	Numberoffreecoursestobedeliveredto Barda NumberoffreecoursestobedeliveredtoBARDA	576000
CY2015Q3	siga	Patent Preparation Fees PatentPreparationFees	194444	USD
	siga	Patent Preparation Fees PatentPreparationFees	762881	USD
CY2016Q3	siga	Patent Preparation Fees PatentPreparationFees	230246	USD
	siga	Patent Preparation Fees PatentPreparationFees	689651	USD
CY2016Q3	siga	Payment To Extend Days To Satisfy Claim PaymentToExtendDaysToSatisfyClaim	90000000	USD
CY2015Q4	siga	Payment To Post Collateral For Surety Bond PaymentToPostCollateralForSuretyBond	1300000	USD
CY2016Q3	siga	Paymenttoextend120daystosatisfypharm Atheneclaim Paymenttoextend120daystosatisfypharmAtheneclaim	20000000	USD
CY2016Q3	siga	Pharm Atheneliabilityincludesreimbursableattorneyandexpertfee PharmAtheneliabilityincludesreimbursableattorneyandexpertfee	3200000	USD
CY2016Q3	siga	Planof Reorganization Termsof Planin Evenof Default Cash Usedas Collateralin Excessof Threshold Threshold Amount PlanofReorganizationTermsofPlaninEvenofDefaultCashUsedasCollateralinExcessofThresholdThresholdAmount	50000000	USD
CY2016Q3	siga	Potential Future Aggregate Research And Development Expenses PotentialFutureAggregateResearchAndDevelopmentExpenses	8300000	USD
	siga	Proceeds From Issuance Of Warrants And Options ProceedsFromIssuanceOfWarrantsAndOptions	12200	USD
	siga	Proceeds From Issuance Of Warrants And Options ProceedsFromIssuanceOfWarrantsAndOptions	0	USD
CY2015Q3	siga	Reorganization Payments ReorganizationPayments	2200000	USD
	siga	Reorganization Payments ReorganizationPayments	5100000	USD
	siga	Reorganization Payments ReorganizationPayments	4600000	USD
CY2015Q3	siga	Reorganization Professional Fees ReorganizationProfessionalFees	486153	USD
	siga	Reorganization Professional Fees ReorganizationProfessionalFees	1555892	USD
CY2016Q3	siga	Reorganization Professional Fees ReorganizationProfessionalFees	0	USD
	siga	Reorganization Professional Fees ReorganizationProfessionalFees	1732521	USD
CY2015Q3	siga	Reorganization Trusteefees ReorganizationTrusteefees	13000	USD
	siga	Reorganization Trusteefees ReorganizationTrusteefees	39000	USD
CY2016Q3	siga	Reorganization Trusteefees ReorganizationTrusteefees	0	USD
	siga	Reorganization Trusteefees ReorganizationTrusteefees	33000	USD
CY2015Q3	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	1327403	USD
	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	3986955	USD
CY2016Q3	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	4658355	USD
	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	7829402	USD
CY2016Q3	siga	Researchand Development Revenue Longterm Contract ResearchandDevelopmentRevenueLongtermContract	4300000	USD
	siga	Researchand Development Revenue Longterm Contract ResearchandDevelopmentRevenueLongtermContract	6400000	USD
CY2015Q3	siga	Restricted Stock Units RestrictedStockUnits	240000	shares
CY2016Q3	siga	Restricted Stock Units RestrictedStockUnits	313337	shares
CY2015Q4	siga	Suretybond Suretybond	2700000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3944476	USD
CY2016Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2925464	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3676730	USD
CY2016Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38747077	USD
CY2015Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	580801	USD
CY2016Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1384184	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3388608	USD
CY2016Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4793300	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	597721	USD
CY2016Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2069198	USD
CY2015Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	227863	USD
CY2016Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	255553	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3299417	USD
CY2016Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3430121	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	177008371	USD
CY2016Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	177530037	USD
CY2015Q4	us-gaap	Assets Assets	185732936	USD
CY2016Q3	us-gaap	Assets Assets	162837339	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	129458829	USD
CY2016Q3	us-gaap	Assets Current AssetsCurrent	86577814	USD
CY2016Q3	us-gaap	Bankruptcy Claims Amount Paid To Settle Claims BankruptcyClaimsAmountPaidToSettleClaims	785000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99713929	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	129289275	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112711028	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20492788	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	29575346	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-92218240	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54114296	shares
CY2016Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53843044	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54114296	shares
CY2016Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53843044	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	5411	USD
CY2016Q3	us-gaap	Common Stock Value CommonStockValue	5411	USD
CY2016Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-8700	USD
	us-gaap	Debtor Reorganization Items Other Expense Income DebtorReorganizationItemsOtherExpenseIncome	5672	USD
CY2015Q3	us-gaap	Debtor Reorganization Items Other Expense Income DebtorReorganizationItemsOtherExpenseIncome	0	USD
CY2015Q3	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	1449543	USD
	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	4279937	USD
CY2016Q3	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	0	USD
	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	1951381	USD
CY2016Q3	us-gaap	Debtor Reorganization Items Other Expense Income DebtorReorganizationItemsOtherExpenseIncome	0	USD
	us-gaap	Debtor Reorganization Items Other Expense Income DebtorReorganizationItemsOtherExpenseIncome	0	USD
CY2015Q4	us-gaap	Deferred Costs DeferredCosts	52936428	USD
CY2016Q3	us-gaap	Deferred Costs DeferredCosts	74388990	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	13543	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	16246	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	255258371	USD
CY2016Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	367123574	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	265643	USD
CY2016Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	281889	USD
CY2015Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	52290	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	199144	USD
CY2016Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	42660	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	130704	USD
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.36
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.54
CY2015Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	452696	USD
CY2016Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	455219	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-238501	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2015Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-13553	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-40291	USD
CY2016Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2015Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2016Q3	us-gaap	Goodwill Goodwill	898334	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	9200000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	29200000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-5564610	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-19119187	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9247714	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-29249368	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	65910	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	238089	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4072	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8692	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	714490	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	385680	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	487600	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	35070347	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	21448121	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	21452562	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	255012995	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	111865203	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-17952529	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5304431	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1347437	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-63171	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	35232	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1835322	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	0	USD
	us-gaap	Interest Expense InterestExpense	266726	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	94776	USD
	us-gaap	Interest Expense InterestExpense	104991	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	12447088	USD
CY2016Q3	us-gaap	Inventory Net InventoryNet	17751519	USD
CY2015Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	12447088	USD
CY2016Q3	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	17751519	USD
CY2015Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2542044	USD
CY2016Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2542043	USD
CY2015Q4	us-gaap	Liabilities Liabilities	470161486	USD
CY2016Q3	us-gaap	Liabilities Liabilities	476002283	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	185732936	USD
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	162837339	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	5832624	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7333084	USD
CY2016Q3	us-gaap	Liabilities Current LiabilitiesCurrent	108327773	USD
CY2015Q4	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	206972170	USD
CY2016Q3	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	0	USD
	us-gaap	Liabilities Subject To Compromise Period Increase Decrease LiabilitiesSubjectToCompromisePeriodIncreaseDecrease	-206412018	USD
	us-gaap	Liabilities Subject To Compromise Period Increase Decrease LiabilitiesSubjectToCompromisePeriodIncreaseDecrease	-206972170	USD
CY2015Q3	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	0	USD
	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	0	USD
CY2016Q3	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	3566451	USD
	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	10716276	USD
CY2015Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	205400068	USD
CY2015Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	0	USD
CY2016Q3	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	93700000	USD
CY2016Q3	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	93654855	USD
CY2016Q3	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	94000000	USD
	us-gaap	Loss Contingency Accrual Carrying Value Period Increase Decrease LossContingencyAccrualCarryingValuePeriodIncreaseDecrease	0	USD
	us-gaap	Loss Contingency Accrual Carrying Value Period Increase Decrease LossContingencyAccrualCarryingValuePeriodIncreaseDecrease	93654855	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1987800	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1294501	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3936834	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10997	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27626312	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-90912742	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-5630520	USD
	us-gaap	Net Income Loss NetIncomeLoss	-19357276	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-9243642	USD
	us-gaap	Net Income Loss NetIncomeLoss	-29258060	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12483	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	28823	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	30756	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	100556	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	4955800	USD
	us-gaap	Operating Expenses OperatingExpenses	16987738	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	12720519	USD
	us-gaap	Operating Expenses OperatingExpenses	32235903	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3628397	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13000783	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8062164	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24406501	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1982223	USD
CY2016Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1084365	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1989520	USD
CY2016Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	642083	USD
CY2015Q4	us-gaap	Other Liabilities OtherLiabilities	332218	USD
CY2016Q3	us-gaap	Other Liabilities OtherLiabilities	269047	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	10052	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	0	USD
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	115000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-4000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	0	USD
	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	1294501	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	63166	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10997	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	623983	USD
CY2016Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9586430	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3749242	USD
CY2016Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3760239	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	449825	USD
CY2016Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	330118	USD
CY2015Q3	us-gaap	Reorganization Items ReorganizationItems	1948696	USD
	us-gaap	Reorganization Items ReorganizationItems	5880501	USD
CY2016Q3	us-gaap	Reorganization Items ReorganizationItems	0	USD
	us-gaap	Reorganization Items ReorganizationItems	3716902	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2426567	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8197068	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6068567	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11553469	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-461442332	USD
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-490700392	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2321236	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7987498	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2855255	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9276507	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1225305	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	521666	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-284428550	USD
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	-313164944	USD
CY2015Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2016Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6954154	USD
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	53919896	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	53668463	shares
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54284296	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54205354	shares

Files In Submission

Name	View Source	Status
0001010086-16-000030-index-headers.html	Edgar Link	pending
0001010086-16-000030-index.html	Edgar Link	pending
0001010086-16-000030.txt	Edgar Link	pending
0001010086-16-000030-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20160930.xml	Edgar Link	completed
siga-20160930.xsd	Edgar Link	pending
siga-20160930x10q.htm	Edgar Link	pending
siga-20160930_cal.xml	Edgar Link	unprocessable
siga-20160930_def.xml	Edgar Link	unprocessable
siga-20160930_lab.xml	Edgar Link	unprocessable
siga-20160930_pre.xml	Edgar Link	unprocessable
siga-exhibit3112016q3.htm	Edgar Link	pending
siga-exhibit3122016q3.htm	Edgar Link	pending
siga-exhibit3212016q3.htm	Edgar Link	pending
sigaexhibit3222016q3.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA TECHNOLOGIES INC Stock $siga

2016 Q4 Form 10-Q Financial Statement

#000101008616000030 Filed on November 02, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA TECHNOLOGIES INC Stock $siga

2016 Q4 Form 10-Q Financial Statement

#000101008616000030 Filed on November 02, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA TECHNOLOGIES INC Stock $siga